Omalizumab, the innovative biologic that disrupted the market of the treatment of allergic diseases
Omalizumab, the blockbuster monoclonal antibody anti-IgE that revolutionized the market by the disruptive innovation that supposed more than 20 years ago. This biological drug changed the paradigm of the treatment of allergic diseases, particularly severe allergic asthma and chronic spontaneous u...
| Main Authors: | , |
|---|---|
| Format: | info:eu-repo/semantics/bachelorThesis |
| Language: | eng |
| Published: |
2023
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/10171/66799 |